Case Report July 15, 2021

Aripiprazole-Induced Skin Reaction

; ; ; ; ; ;

Prim Care Companion CNS Disord 2021;23(4):20l02772

  1. Warnock JK, Morris DW. Adverse cutaneous reactions to antipsychotics. Am J Clin Dermatol. 2002;3(9):629–636. PubMed CrossRef
  2. de Bartolomeis A, Tomasetti C, Iasevoli F. Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism. CNS Drugs. 2015;29(9):773–799. PubMed CrossRef
  3. Parker C. Aripiprazole induced severe and extensive skin reaction: a case report. Ther Adv Psychopharmacol. 2012;2(5):195–198. PubMed CrossRef
  4. Argo TR, Carnahan RM, Perry PJ. Aripiprazole, a novel atypical antipsychotic drug. Pharmacotherapy. 2004;24(2):212–228. PubMed CrossRef
  5. Summary of Product Characteristics. Abilify (aripiprazole) [package insert].  Rockville, MD: Otsuka America Pharmaceutical, Inc; 2014.
  6. Nath S, Rehman S, Kalita KN, et al. Aripiprazole-induced skin rash. Ind Psychiatry J. 2016;25(2):225–227. PubMed CrossRef
  7. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev. 2001;53(3):357–379. PubMed
  8. Ancuceanu R, Dinu M, Furtunescu F, et al. An inventory of medicinal products causing skin rash: clinical and regulatory lessons. Exp Ther Med. 2019;18(6):5061–5071. PubMed CrossRef
  9. Haybarger E, Young AS, Giovannitti JA Jr. Benzodiazepine allergy with anesthesia administration: a review of current literature. Anesth Prog. 2016;63(3):160–167. PubMed CrossRef